1.435
price down icon0.35%   -0.005
 
loading
Schlusskurs vom Vortag:
$1.44
Offen:
$1.45
24-Stunden-Volumen:
117.91K
Relative Volume:
0.31
Marktkapitalisierung:
$129.98M
Einnahmen:
-
Nettoeinkommen (Verlust:
$1.60M
KGV:
47.83
EPS:
0.03
Netto-Cashflow:
$-62.91M
1W Leistung:
-1.71%
1M Leistung:
-6.21%
6M Leistung:
-14.07%
1J Leistung:
-27.53%
1-Tages-Spanne:
Value
$1.42
$1.45
1-Wochen-Bereich:
Value
$1.42
$1.52
52-Wochen-Spanne:
Value
$1.13
$2.66

Compugen Ltd Stock (CGEN) Company Profile

Name
Firmenname
Compugen Ltd
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
74
Name
Twitter
@CompugenLtd
Name
Nächster Verdiensttermin
2025-03-04
Name
Neueste SEC-Einreichungen
Name
CGEN's Discussions on Twitter

Vergleichen Sie CGEN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CGEN
Compugen Ltd
1.435 129.98M 0 1.60M -62.91M 0.03
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
506.76 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
571.31 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
631.61 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
259.00 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
250.03 24.70B 3.81B -644.79M -669.77M -6.24

Compugen Ltd Stock (CGEN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-01-13 Eingeleitet Oppenheimer Outperform
2022-08-05 Herabstufung Jefferies Buy → Hold
2020-05-26 Fortgesetzt JMP Securities Mkt Outperform
2020-05-13 Eingeleitet Stifel Buy
2020-05-07 Eingeleitet SVB Leerink Outperform
2020-04-22 Eingeleitet ROTH Capital Buy
2020-03-24 Eingeleitet SunTrust Buy
2020-01-16 Eingeleitet Cantor Fitzgerald Overweight
2018-03-29 Eingeleitet Oppenheimer Outperform
2016-02-01 Fortgesetzt Oppenheimer Outperform
2015-10-15 Eingeleitet FBR Capital Outperform
2015-04-23 Fortgesetzt Jefferies Buy
2015-04-21 Eingeleitet Oppenheimer Outperform
2014-02-07 Eingeleitet MLV & Co Buy
2009-12-28 Bestätigt Cantor Fitzgerald Buy
2009-07-29 Eingeleitet Cantor Fitzgerald Buy
Alle ansehen

Compugen Ltd Aktie (CGEN) Neueste Nachrichten

pulisher
Apr 24, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 24, 2025
pulisher
Apr 13, 2025

67,041 Shares in Compugen Ltd. (NASDAQ:CGEN) Acquired by Raymond James Financial Inc. - Defense World

Apr 13, 2025
pulisher
Apr 13, 2025

Compugen (NASDAQ:CGEN) vs. Quantum Genomics Société Anonyme (OTCMKTS:QNNTF) Financial Review - Defense World

Apr 13, 2025
pulisher
Apr 12, 2025

Commonwealth Equity Services LLC Takes Position in Compugen Ltd. (NASDAQ:CGEN) - Defense World

Apr 12, 2025
pulisher
Apr 12, 2025

Compugen Ltd. Announces Appointment of Alberto Sessa as Chief Financial Officer - marketscreener.com

Apr 12, 2025
pulisher
Apr 09, 2025

Compugen at Stifel Forum: Strategic Insights on Immunotherapy Pipeline By Investing.com - Investing.com South Africa

Apr 09, 2025
pulisher
Apr 09, 2025

Compugen at Stifel Forum: Strategic Insights on Immunotherapy Pipeline - Investing.com Australia

Apr 09, 2025
pulisher
Apr 09, 2025

Is There An Opportunity With Compugen Ltd.'s (NASDAQ:CGEN) 33% Undervaluation? - simplywall.st

Apr 09, 2025
pulisher
Apr 07, 2025

Compugen at Needham Conference: Strategic Immuno-Oncology Insights - Investing.com Australia

Apr 07, 2025
pulisher
Apr 07, 2025

Compugen at Needham Conference: Strategic Immuno-Oncology Insights By Investing.com - Investing.com India

Apr 07, 2025
pulisher
Apr 05, 2025

Compugen stock touches 52-week low at $1.35 amid market challenges - Investing.com Canada

Apr 05, 2025
pulisher
Apr 04, 2025

Compugen stock touches 52-week low at $1.35 amid market challenges By Investing.com - Investing.com South Africa

Apr 04, 2025
pulisher
Apr 03, 2025

BeiGene stock slips on trial discontinuation (ONC:NASDAQ) - Seeking Alpha

Apr 03, 2025
pulisher
Apr 02, 2025

Compugen at AI Drug Discovery Conference: Strategic Partnerships Drive Progress - Investing.com

Apr 02, 2025
pulisher
Mar 26, 2025

Cancer AI Breakthrough: Compugen Takes Center Stage at 3 Elite Healthcare Forums - Stock Titan

Mar 26, 2025
pulisher
Mar 23, 2025

Compugen Ltd. (CGEN): Among the Penny Stocks With Huge Upside Potential According to Analysts - MSN

Mar 23, 2025
pulisher
Mar 23, 2025

Compugen Ltd. (NASDAQ:CGEN) Shares Acquired by Connor Clark & Lunn Investment Management Ltd. - Defense World

Mar 23, 2025
pulisher
Mar 21, 2025

Reviewing Aligos Therapeutics (NASDAQ:ALGS) and Compugen (NASDAQ:CGEN) - Armenian Reporter

Mar 21, 2025
pulisher
Mar 12, 2025

Compugen at Leerink’s Global Healthcare Conference: Strategic Insights By Investing.com - Investing.com South Africa

Mar 12, 2025
pulisher
Mar 11, 2025

Compugen at Leerink’s Global Healthcare Conference: Strategic Insights - Investing.com

Mar 11, 2025
pulisher
Mar 10, 2025

Oppenheimer & Co. Inc. Raises Stock Position in Compugen Ltd. (NASDAQ:CGEN) - Defense World

Mar 10, 2025
pulisher
Mar 09, 2025

Earnings call transcript: Compugen Q4 2024 reveals revenue decline By Investing.com - Investing.com Australia

Mar 09, 2025
pulisher
Mar 07, 2025

Compugen Ltd. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 07, 2025

Compugen (NASDAQ:CGEN) Rating Lowered to Hold at StockNews.com - Defense World

Mar 07, 2025
pulisher
Mar 05, 2025

Rodman & Renshaw maintains $4 price target on Compugen stock By Investing.com - Investing.com Australia

Mar 05, 2025
pulisher
Mar 05, 2025

Compugen Ltd. (NASDAQ:CGEN) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 05, 2025
pulisher
Mar 05, 2025

Compugen Ltd (CGEN) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - GuruFocus.com

Mar 05, 2025
pulisher
Mar 04, 2025

Compugen’s 2024 Results Highlight Clinical Progress and Financial Stability - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Earnings call transcript: Compugen Q4 2024 reveals revenue decline - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

Rodman & Renshaw maintains $4 price target on Compugen stock - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

Compugen Ltd reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 04, 2025
pulisher
Mar 04, 2025

Compugen (CGEN) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance

Mar 04, 2025
pulisher
Mar 04, 2025

Compugen: Q4 Earnings Snapshot - CTPost

Mar 04, 2025
pulisher
Mar 04, 2025

Compugen earnings missed by $0.09, revenue fell short of estimates - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 04, 2025

Compugen Reports 2024 Financial Results and Clinical Progress - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Compugen: Q4 Earnings Snapshot -March 04, 2025 at 07:23 am EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Compugen Reports Fourth Quarter and Full Year 2024 Results -March 04, 2025 at 07:13 am EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Compugen reports Q4 EPS (7c) vs. 11c last year - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Earnings Flash (CGEN) COMPUGEN LTD. Posts Q4 Loss $-0.07 Per Share -March 04, 2025 at 07:08 am EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Earnings Flash (CW9) COMPUGEN LTD. Posts Q4 Revenue $1.5M - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Earnings Flash (CGEN) COMPUGEN LTD. Posts Q4 Revenue $1.5M -March 04, 2025 at 07:09 am EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

How Compugen's Cancer Immunotherapy Pipeline Is Advancing While Extending Cash Runway to 2027 - StockTitan

Mar 04, 2025
pulisher
Mar 03, 2025

Cancer Immunotherapy Pioneer Compugen to Share Insights at Major Healthcare Conference - StockTitan

Mar 03, 2025
pulisher
Mar 03, 2025

Compugen to Participate in a Fireside Chat at the 2025 Leerink Partners Global Healthcare Conference - Yahoo Finance

Mar 03, 2025

Finanzdaten der Compugen Ltd-Aktie (CGEN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.90
price up icon 1.36%
$69.80
price up icon 0.31%
$32.42
price down icon 0.60%
$24.00
price up icon 0.25%
$103.85
price down icon 0.51%
biotechnology ONC
$249.09
price down icon 0.47%
Kapitalisierung:     |  Volumen (24h):